Protein quantification using LC-MS: Can it make a difference?

Bioanalysis

Volumn 4, Issue 17, 2012, Pages 2113-2116

  Van De Merbel, Nico C ^a,b   Bronsema, Kees J ^a,b   Nemansky, Martin ^a  

^a PRA Health Sciences   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

internal standards; LC MS; protein quantification; sample preparation

Indexed keywords

DRUG ANTIBODY; PEPTIDE; PROTEIN;

ANTIBODY RESPONSE; BIOASSAY; BIOTECHNOLOGY; CHEMICAL COMPOSITION; CROSS REACTION; DRUG SCREENING; GENETIC SCREENING; IMMUNOGENICITY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR GENETICS; NOTE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RELIABILITY;

CHROMATOGRAPHY, LIQUID; HUMANS; PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84866952756     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.190     Document Type: Note

References (15)

1. Yang Z, Ke J, Hayes M, Bryant M, Tse FLS. A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon-a2a in human serum using monolithic C18 solid phase extraction for enrichment. J. Chromatogr. B 877(18-19), 1737-1742 (2009
2. Halquist MS, Karnes HT. Quantification of Alefacept, an immunosuppressive fusion protein in human plasma using a protein analogue internal standard, trypsin cleaved signature peptides and liquid chromatography tandem mass spectrometry. J. Chromatogr. B 879(11-12), 789-798 (2011
3. Yang Z, Hayes M, Fang X et al. LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D solid-phase extraction cleanup. Anal. Chem. 79(24), 9294-9301 (2007 (Pubitemid 350276306)
4. Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS. Bioanalysis 3(12), 1379-1397 (2011
5. Campbell JL, Le Blanc JCY. Peptide and protein drug analysis by MS: Challenges and opportunities for the discovery environment. Bioanalysis 3(6), 645-657 (2011
6. Bronsema KJ, Bischoff R, van de Merbel NC. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. J. Chromatogr. B 893-894, 1-14 (2012
7. Becker JO, Hoofnagle AN. Replacing immunoassays with tryptic digestion peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis 4(3), 281-290 (2012
8. Li F, Fast D, Michael S. Absolute quantitation of protein therapeutics in biological matrices by enzymatic digestion and LC-MS. Bioanalysis 3(21), 2459-2480 (2011
9. Nowatzke WL, Rogers K, Wells E et al. Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs. Bioanalysis 3(5), 509-521 (2011
10. Findlay JWA. Specificity of bioanalytical methods for pharmacokinetic support of biological macromolecular therapeutics is important. Bioanalysis 3(6), 567-569 (2011
11. Kay RG, Roberts A. Bioanalysis of biotherapeutic proteins and peptides: Immunological or MS approach? Bioanalysis 4(8), 857-860 (2012
12. Timmerman P, Lausecker B, Barosso B et al. 'Large meets small': Connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS). Bioanalysis 4(6), 627-631 (2012
13. Swann PG, Shapiro MA. Regulatory considerations for development of bioanalytical assays for biotechnology products. Bioanalysis 3(6), 597-603 (2011
14. Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J. Immunol. Meth. 347(1-2), 3-11 (2009
15. Ezan E, Bitsch F. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. Bioanalysis 1(8), 1375-1388 (2009